Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Hexo Corp    HEXO   CA4283041099

HEXO CORP

(HEXO)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
07/09/2019 07/10/2019 07/11/2019 07/12/2019 07/15/2019 Date
6.78(c) 6.67(c) 6.69(c) 6.33(c) 6.58(c) Last
1 342 131 868 348 845 427 1 837 617 1 283 858 Volume
+2.42% -1.62% +0.30% -5.38% +3.95% Change
More quotes
Financials ()
Sales 2019 59,6 M
EBIT 2019 -47,0 M
Net income 2019 -35,4 M
Finance 2019 171 M
Yield 2019 -
Sales 2020 345 M
EBIT 2020 16,6 M
Net income 2020 46,3 M
Finance 2020 125 M
Yield 2020 -
P/E ratio 2019 -37,2x
P/E ratio 2020 51,1x
EV / Sales2019 25,5x
EV / Sales2020 4,54x
Capitalization 1 690 M
More Financials
Company
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while... 
Sector
Pharmaceuticals
Calendar
10/24Earnings Release
More about the company
Surperformance© ratings of Hexo Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on HEXO CORP
07/11HEXO CORP : to transfer listing to the New York Stock Exchange
AQ
07/10GrowGeneration Names Former Home Depot CEO Nardelli as Senior Strategic Advis..
DJ
07/10Cannabis Startup Hires Ex-Kellogg Finance Chief -- WSJ
DJ
07/09Cannabis Startup Surterra Wellness Appoints Former Kellogg CFO as Finance Chi..
DJ
07/08Ontario's slow rollout of weed outlets could help black market
RE
06/13HEXO : plans to enter 8 U.S. states in 2020 with CBD products
AQ
06/13HEXO MED, an affiliate of HEXO Corp, secures medical cannabis license in Euro..
GL
06/12HEXO Corp reports third quarter 2019 financial results 
GL
06/10HEXO Corp to announce third quarter fiscal 2019 results and webcast
GL
05/29HEXO CORP : formalizes US presence by naming Michael Monahan as Chief Financial ..
AQ
More news
Analyst Recommendations on HEXO CORP
More recommendations
Sector news : Alternative Medicine
08:24aJOHNSON & JOHNSON : beats profit estimates on pharma strength, raises sales outl..
RE
08:23aJOHNSON & JOHNSON : beats profit estimates on pharma strength, raises sales outl..
RE
07:44aJOHNSON & JOHNSON : Bumps Up Sales Target--Update
DJ
07:39aJOHNSON & JOHNSON : Bumps Up Sales Target
DJ
06:52aNOVARTIS : Gets FDA Priority Review for Sickle-Cell Disease Medicine Crizanlizum..
DJ
More sector news : Alternative Medicine
Chart HEXO CORP
Duration : Period :
Hexo Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEXO CORP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 10,7  CAD
Last Close Price 6,58  
Spread / Highest target 113%
Spread / Average Target 62,4%
Spread / Lowest Target 17,0%
EPS Revisions
Managers
NameTitle
Sébastien St. Louis President, Chief Executive Officer & Director
Ed M. Chaplin Chief Financial Officer
Michael Munzar Director & Medical Director
Adam Miron Director & Chief Brand Officer
Jason G. Ewart Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HEXO CORP39.70%1 314
CANOPY GROWTH CORP25.16%12 811
AURORA CANNABIS INC34.66%7 286
BEIJING TONGRENTANG CO., LTD.8.33%5 979
CRONOS GROUP INC34.98%5 074
DONG-E-E-JIAO CO LTD--.--%3 752